SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Name of study: 
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Targeted disease: 
Lung Cancer

Purpose of study:
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical trial enrollment (CTE), as well as the financial impact, and potential outcomes of the intervention.

Is the study of a controlled or observational design? 
Observational

Where is the study being conducted?
Multi-Center Trial

Lead Institution:
Massive Bio, Inc

City and State: 
Nationwide

When the study is being conducted: 
Start Date: 1/1/2018
End date: 12/1/2022

What website should a person use to register for the study?
Massivebio.com

Who should a person contact to register for the study?
Name: Massive Bio
Phone: 844-627-7246
Email: [email protected]

Who is sponsoring this study?
Massive Bio, Inc.

What is the identifier for this study on ClinicalTrials.gov?
NCT03452774

Page last updated: December 3, 2020

No upcoming events near you